The aim of the study was to evaluate the potential of using solid lipid microparticles (SLM) for the delivery of controlled release formulation to the respiratory tract. salbutamol was chosen as a drug since it is widely used for the treatment of bronchial asthma. SLM, containing, salbutamol, were prepared using stearic acid as the lipidic materialand phosphatidylcholine as the surfactant, by the classical melt emulsification method and or the spray congealing technique with pneumatic atomizer. Initial release studies on the SLM obtained with the traditional method indicated the lack of release modulation, with 90% of salbutamol released after 5 min. This can be traced to the hydrophilic characteristics of the drug. In order to overcome this limitation, the spray congealing technique was employed. release studies performed on the SLM produced by the spray congealing method showed a significant reduction in release, with only 65% of the drug released after 24 h. The obtained results demonstrated that for polar drug the preparation technique plays a major role in the lipid microparticle incorporation process. This effect could be attributed to the fact that the fprmer production method permits better drug entrapment within the particles.

Incorporation of salbutamol in solid lipid microparticles

ALBERTINI, BEATRICE;PASSERINI, NADIA;RODRIGUEZ, LORENZO;
2011

Abstract

The aim of the study was to evaluate the potential of using solid lipid microparticles (SLM) for the delivery of controlled release formulation to the respiratory tract. salbutamol was chosen as a drug since it is widely used for the treatment of bronchial asthma. SLM, containing, salbutamol, were prepared using stearic acid as the lipidic materialand phosphatidylcholine as the surfactant, by the classical melt emulsification method and or the spray congealing technique with pneumatic atomizer. Initial release studies on the SLM obtained with the traditional method indicated the lack of release modulation, with 90% of salbutamol released after 5 min. This can be traced to the hydrophilic characteristics of the drug. In order to overcome this limitation, the spray congealing technique was employed. release studies performed on the SLM produced by the spray congealing method showed a significant reduction in release, with only 65% of the drug released after 24 h. The obtained results demonstrated that for polar drug the preparation technique plays a major role in the lipid microparticle incorporation process. This effect could be attributed to the fact that the fprmer production method permits better drug entrapment within the particles.
2011
Pharmaceutical Sciences for the Future of Medicines
SC-41
SC-41
S. Scalia; B. Albertini; N. Passerini; L. Rodriguez; D. Young
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/111677
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact